138 related articles for article (PubMed ID: 32320473)
1. High somatostatin receptor expression and efficacy of somatostatin analogues in patients with metastatic Merkel cell carcinoma.
Akaike T; Qazi J; Anderson A; Behnia FS; Shinohara MM; Akaike G; Hippe DS; Thomas H; Takagishi SR; Lachance K; Park SY; Tarabadkar ES; Iyer JG; Blom A; Parvathaneni U; Vesselle H; Nghiem P; Bhatia S
Br J Dermatol; 2021 Feb; 184(2):319-327. PubMed ID: 32320473
[TBL] [Abstract][Full Text] [Related]
2. SSTR Antagonists as Theranostic Option in Merkel Cell Carcinoma.
Kircher M; Amerein A; Augustin M; Reitsam NG; Enke JS; Patt M; Wienand G; Bundschuh RA; Pfob CH; Lapa C; Dierks A
J Nucl Med; 2024 Feb; 65(6):988-9. PubMed ID: 38331456
[No Abstract] [Full Text] [Related]
3. Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial.
D'Angelo SP; Bhatia S; Brohl AS; Hamid O; Mehnert JM; Terheyden P; Shih KC; Brownell I; Lebbé C; Lewis KD; Linette GP; Milella M; Georges S; Shah P; Ellers-Lenz B; Bajars M; Güzel G; Nghiem PT
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32414862
[TBL] [Abstract][Full Text] [Related]
4. Clinical benefit of baseline imaging in Merkel cell carcinoma: Analysis of 584 patients.
Singh N; Alexander NA; Lachance K; Lewis CW; McEvoy A; Akaike G; Byrd D; Behnia S; Bhatia S; Paulson KG; Nghiem P
J Am Acad Dermatol; 2021 Feb; 84(2):330-339. PubMed ID: 32707254
[TBL] [Abstract][Full Text] [Related]
5. Postoperative, Single-Fraction Radiation Therapy in Merkel Cell Carcinoma of the Head and Neck.
Cook MM; Schaub SK; Goff PH; Fu A; Park SY; Hippe DS; Liao JJ; Apisarnthanarax S; Bhatia S; Tseng YD; Nghiem PT; Parvathaneni U
Adv Radiat Oncol; 2020; 5(6):1248-1254. PubMed ID: 32838069
[TBL] [Abstract][Full Text] [Related]
6. Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study.
Najjar YG; Navrazhina K; Ding F; Bhatia R; Tsai K; Abbate K; Durden B; Eroglu Z; Bhatia S; Park S; Chowdhary A; Chandra S; Kennedy J; Puzanov I; Ernstoff M; Vachhani P; Drabick J; Singh A; Xu T; Yang J; Carvajal R; Manson D; Kirkwood JM; Cohen J; Sullivan R; Johnson D; Funchain P; Shoushtari A
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581057
[TBL] [Abstract][Full Text] [Related]
7. Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma.
Algazi AP; Twitty CG; Tsai KK; Le M; Pierce R; Browning E; Hermiz R; Canton DA; Bannavong D; Oglesby A; Francisco M; Fong L; Pittet MJ; Arlauckas SP; Garris C; Levine LP; Bifulco C; Ballesteros-Merino C; Bhatia S; Gargosky S; Andtbacka RHI; Fox BA; Rosenblum MD; Daud AI
Clin Cancer Res; 2020 Jun; 26(12):2827-2837. PubMed ID: 32376655
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptors: an alternative treatment target for advanced Merkel cell carcinoma.
Br J Dermatol; 2021 Feb; 184(2):e32-e52. PubMed ID: 33544438
[TBL] [Abstract][Full Text] [Related]
9. Men's experiences of radiotherapy treatment for localized prostate cancer and its long-term treatment side effects: a longitudinal qualitative study.
Sutton E; Lane JA; Davis M; Walsh EI; Neal DE; Hamdy FC; Mason M; Staffurth J; Martin RM; Metcalfe C; Peters TJ; Donovan JL; Wade J;
Cancer Causes Control; 2021 Mar; 32(3):261-269. PubMed ID: 33394204
[TBL] [Abstract][Full Text] [Related]
10. Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial.
Ferreira JP; Claggett BL; Liu J; Desai AS; Pfeffer MA; Anand IS; van Veldhuisen DJ; Kober L; Cleland JGF; Rouleau JL; Packer M; Zile MR; Shi VC; Lefkowitz MP; Shah SJ; Vardeny O; Zannad F; Solomon SD; McMurray JJV
Eur J Heart Fail; 2021 May; 23(5):776-784. PubMed ID: 33609066
[TBL] [Abstract][Full Text] [Related]
11. Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East Asians.
Tam CHT; Lim CKP; Luk AOY; Ng ACW; Lee HM; Jiang G; Lau ESH; Fan B; Wan R; Kong APS; Tam WH; Ozaki R; Chow EYK; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JYY; Tsang MW; Kam G; Lau IT; Li JKY; Yeung VTF; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Hu M; Yu W; Tsui SKW; Huang Y; Lan H; Szeto CC; Tang NLS; Ng MCY; So WY; Tomlinson B; Chan JCN; Ma RCW; ;
Genome Med; 2021 Feb; 13(1):29. PubMed ID: 33608049
[TBL] [Abstract][Full Text] [Related]
12. Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Children With Liver Transplant and Native Liver Disease: An International Observational Registry Study.
Kehar M; Ebel NH; Ng VL; Baquero JER; Leung DH; Slowik V; Ovchinsky N; Shah AA; Arnon R; Miloh T; Gupta N; Mohammad S; Kogan-Liberman D; Squires JE; Sanchez MC; Hildreth A; Book L; Chu C; Alrabadi L; Azzam R; Chepuri B; Elisofon S; Falik R; Gallagher L; Kader H; Mogul D; Mujawar Q; Namjoshi SS; Valentino PL; Vitola B; Waheed N; Zheng MH; Lobritto S; Martinez M
J Pediatr Gastroenterol Nutr; 2021 Jun; 72(6):807-814. PubMed ID: 33605666
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic and Genomic Analysis of
Momeni-Boroujeni A; Dahoud W; Vanderbilt CM; Chiang S; Murali R; Rios-Doria EV; Alektiar KM; Aghajanian C; Abu-Rustum NR; Ladanyi M; Ellenson LH; Weigelt B; Soslow RA
Clin Cancer Res; 2021 May; 27(9):2613-2623. PubMed ID: 33602681
[TBL] [Abstract][Full Text] [Related]
14. Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease.
Somineni HK; Nagpal S; Venkateswaran S; Cutler DJ; Okou DT; Haritunians T; Simpson CL; Begum F; Datta LW; Quiros AJ; Seminerio J; Mengesha E; Alexander JS; Baldassano RN; Dudley-Brown S; Cross RK; Dassopoulos T; Denson LA; Dhere TA; Iskandar H; Dryden GW; Hou JK; Hussain SZ; Hyams JS; Isaacs KL; Kader H; Kappelman MD; Katz J; Kellermayer R; Kuemmerle JF; Lazarev M; Li E; Mannon P; Moulton DE; Newberry RD; Patel AS; Pekow J; Saeed SA; Valentine JF; Wang MH; McCauley JL; Abreu MT; Jester T; Molle-Rios Z; Palle S; Scherl EJ; Kwon J; Rioux JD; Duerr RH; Silverberg MS; Zwick ME; Stevens C; Daly MJ; Cho JH; Gibson G; McGovern DPB; Brant SR; Kugathasan S
Am J Hum Genet; 2021 Mar; 108(3):431-445. PubMed ID: 33600772
[TBL] [Abstract][Full Text] [Related]
15. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
Coignard J; Lush M; Beesley J; O'Mara TA; Dennis J; Tyrer JP; Barnes DR; McGuffog L; Leslie G; Bolla MK; Adank MA; Agata S; Ahearn T; Aittomäki K; Andrulis IL; Anton-Culver H; Arndt V; Arnold N; Aronson KJ; Arun BK; Augustinsson A; Azzollini J; Barrowdale D; Baynes C; Becher H; Bermisheva M; Bernstein L; Białkowska K; Blomqvist C; Bojesen SE; Bonanni B; Borg A; Brauch H; Brenner H; Burwinkel B; Buys SS; Caldés T; Caligo MA; Campa D; Carter BD; Castelao JE; Chang-Claude J; Chanock SJ; Chung WK; Claes KBM; Clarke CL; ; ; Collée JM; Conroy DM; Czene K; Daly MB; Devilee P; Diez O; Ding YC; Domchek SM; Dörk T; Dos-Santos-Silva I; Dunning AM; Dwek M; Eccles DM; Eliassen AH; Engel C; Eriksson M; Evans DG; Fasching PA; Flyger H; Fostira F; Friedman E; Fritschi L; Frost D; Gago-Dominguez M; Gapstur SM; Garber J; Garcia-Barberan V; García-Closas M; García-Sáenz JA; Gaudet MM; Gayther SA; Gehrig A; Georgoulias V; Giles GG; Godwin AK; Goldberg MS; Goldgar DE; González-Neira A; Greene MH; Guénel P; Haeberle L; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Harrington PA; Hart SN; He W; Hogervorst FBL; Hollestelle A; Hopper JL; Horcasitas DJ; Hulick PJ; Hunter DJ; Imyanitov EN; ; ; ; Jager A; Jakubowska A; James PA; Jensen UB; John EM; Jones ME; Kaaks R; Kapoor PM; Karlan BY; Keeman R; Khusnutdinova E; Kiiski JI; Ko YD; Kosma VM; Kraft P; Kurian AW; Laitman Y; Lambrechts D; Le Marchand L; Lester J; Lesueur F; Lindstrom T; Lopez-Fernández A; Loud JT; Luccarini C; Mannermaa A; Manoukian S; Margolin S; Martens JWM; Mebirouk N; Meindl A; Miller A; Milne RL; Montagna M; Nathanson KL; Neuhausen SL; Nevanlinna H; Nielsen FC; O'Brien KM; Olopade OI; Olson JE; Olsson H; Osorio A; Ottini L; Park-Simon TW; Parsons MT; Pedersen IS; Peshkin B; Peterlongo P; Peto J; Pharoah PDP; Phillips KA; Polley EC; Poppe B; Presneau N; Pujana MA; Punie K; Radice P; Rantala J; Rashid MU; Rennert G; Rennert HS; Robson M; Romero A; Rossing M; Saloustros E; Sandler DP; Santella R; Scheuner MT; Schmidt MK; Schmidt G; Scott C; Sharma P; Soucy P; Southey MC; Spinelli JJ; Steinsnyder Z; Stone J; Stoppa-Lyonnet D; Swerdlow A; Tamimi RM; Tapper WJ; Taylor JA; Terry MB; Teulé A; Thull DL; Tischkowitz M; Toland AE; Torres D; Trainer AH; Truong T; Tung N; Vachon CM; Vega A; Vijai J; Wang Q; Wappenschmidt B; Weinberg CR; Weitzel JN; Wendt C; Wolk A; Yadav S; Yang XR; Yannoukakos D; Zheng W; Ziogas A; Zorn KK; Park SK; Thomassen M; Offit K; Schmutzler RK; Couch FJ; Simard J; Chenevix-Trench G; Easton DF; Andrieu N; Antoniou AC
Nat Commun; 2021 Feb; 12(1):1078. PubMed ID: 33597508
[TBL] [Abstract][Full Text] [Related]
16. Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
Hanna NH; Robinson AG; Temin S; Baker S; Brahmer JR; Ellis PM; Gaspar LE; Haddad RY; Hesketh PJ; Jain D; Jaiyesimi I; Johnson DH; Leighl NB; Moffitt PR; Phillips T; Riely GJ; Rosell R; Schiller JH; Schneider BJ; Singh N; Spigel DR; Tashbar J; Masters G
J Clin Oncol; 2021 Mar; 39(9):1040-1091. PubMed ID: 33591844
[TBL] [Abstract][Full Text] [Related]
17. European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics.
Thyssen JP; Vestergaard C; Barbarot S; de Bruin-Weller MS; Bieber T; Taieb A; Seneschal J; Cork MJ; Paul C; Flohr C; Weidinger S; Trzeciak M; Werfel T; Heratizadeh A; Darsow U; Simon D; Torrelo A; Chernyshov PV; Stalder JF; Gelmetti C; Szalai Z; Svensson Å; von Kobyletzki LB; De Raeve L; Fölster-Holst R; Christen-Zaech S; Hijnen DJ; Gieler U; Gutermuth J; Bangert C; Spuls PI; Kunz B; Ring J; Wollenberg A; Deleuran M
J Eur Acad Dermatol Venereol; 2021 May; 35(5):e308-e311. PubMed ID: 33587756
[No Abstract] [Full Text] [Related]
18. A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndrome.
Roboz GJ; Desai P; Lee S; Ritchie EK; Winer ES; DeMario M; Brennan B; Nüesch E; Chesne E; Brennan L; Lechner K; Kornacker M; DeAngelo DJ
Leuk Lymphoma; 2021 Jul; 62(7):1740-1748. PubMed ID: 33586590
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 as a biomarker of response to immune-checkpoint inhibitors.
Doroshow DB; Bhalla S; Beasley MB; Sholl LM; Kerr KM; Gnjatic S; Wistuba II; Rimm DL; Tsao MS; Hirsch FR
Nat Rev Clin Oncol; 2021 Jun; 18(6):345-362. PubMed ID: 33580222
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer.
Monjazeb AM; Giobbie-Hurder A; Lako A; Thrash EM; Brennick RC; Kao KZ; Manuszak C; Gentzler RD; Tesfaye A; Jabbour SK; Alese OB; Rahma OE; Cleary JM; Sharon E; Mamon HJ; Cho M; Streicher H; Chen HX; Ahmed MM; Mariño-Enríquez A; Kim-Schulze S; Gnjatic S; Maverakis E; Marusina AI; Merleev AA; Severgnini M; Pfaff KL; Lindsay J; Weirather JL; Ranasinghe S; Spektor A; Rodig SJ; Hodi SF; Schoenfeld JD
Clin Cancer Res; 2021 May; 27(9):2470-2480. PubMed ID: 33568343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
